Article
High Prevalence of Azithromycin-Resistant Neisseria gonorrhoeae Isolates With a Multidrug Resistance Phenotype in Fukuoka, Japan.
Sexually transmitted diseases - 1 Jun 2015
Tanaka Masatoshi, Furuya Ryusaburo, Irie Shinichiro, Kanayama Akiko, Kobayashi Intetsu
Abstract excerpt
BACKGROUND: The current guidelines recommend a combination of ceftriaxone and azithromycin as a first-line treatment of gonorrhea in the United States and Europe. Despite not being recommended as a first-line regimen in Japan, an oral 2-g dose of azithromycin did become available for gonococcal infections in 2009. Recently, the emergence of azithromycin-resistant Neisseria gonorrhoeae isolates has been reported...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
